Active

TVM Capital Life Science

Investor type

PE

Founded

1984

AUM

$900 M

Location

München, Bavaria, Germany

Investment Ticket

$10-50 m

Investment Stage

Series B Series A

Region of investment

North America Europe Africa Asia
Investor profile last updated: 17 November, 2025

Profile

TVM Capital Healthcare is a globally active healthcare private equity firm with emerging markets strength. We bring over 35 years of international healthcare investment experience to some of the fastest-growing healthcare markets in the world and are uniquely placed to connect East and West; with local skills and abilities on-the-ground across Southeast Asia, and the MENAT region to help transformational healthcare companies to execute on their growth plans.

Industry

Healthcare Services Biotechnology Marketing and Advertising Medical Devices Pharmaceuticals Real Estate Robotics MedTech Life Sciences Infrastructure HealthTech AdTech Media and Entertainment SaaS Software Telecommunications Energy

TVM Capital Life Science Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
TVM Capital Life Science Fund II
Fund of funds
Healthcare Services
Media and Entertainment
Real Estate
SaaS
Software
Telecommunications
Energy
HealthTech
Seed
Series A
Series B
North America
Europe
$5-10 m
$478 M
October 2020

Contacts

Name
Title
Email
avatar
Charles P. (Chad) Floe Operating Partner &Managing Director
Operating Partner &Managing Director
-
avatar
Dr. Helmut M. Schuehsler Chairman & CEO
Chairman & CEO
-
Upgrade to see contacts
avatar
pFPfuHUTsS1gK84N pFPfuHUTsS1gK84N
pFPfuHUTsS1gK84N
avatar
pFPfuHUTsS1gK84N pFPfuHUTsS1gK84N
pFPfuHUTsS1gK84N
avatar
pFPfuHUTsS1gK84N pFPfuHUTsS1gK84N
pFPfuHUTsS1gK84N
Investment-team contacts for TVM Capital Life Science — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about TVM Capital Life Science

TVM Capital Life Science is a private equity firm. It backs companies at Series B and Series A, writing tickets of $10-50 m.
TVM Capital Life Science is located in München, Bavaria, Germany.
TVM Capital Life Science was founded in 1984.
TVM Capital Life Science invests in companies and startups in Healthcare Services, Biotechnology, Marketing and Advertising, Medical Devices, Pharmaceuticals, Real Estate, Robotics, MedTech, Life Sciences, Infrastructure, HealthTech, AdTech, Media and Entertainment, SaaS, Software, Telecommunications, Energy.
TVM Capital Life Science invests in companies and startups in North America, Europe, Africa, Asia.
TVM Capital Life Science invests in companies and startups at Series B, Series A.
TVM Capital Life Science usually invests $10-50 m on average.
TVM Capital Life Science has around $900m assets under management.
TVM Capital Life Science last fund was created/launched in 2020-10-28
TVM Capital Life Science can be reached through its website tvm-capital.com, its LinkedIn page and its X account. Its general enquiries address is brandstatter@tvmcapitalhealthcare.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for TVM Capital Life Science — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query TVM Capital Life Science directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 17 November, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.